Masimo Corp
MASI145.720USD
-1.720-1.17%
Handelsschluss 09/15, 16:00（ET）Kurse um 15 Minuten verzögert
7.91BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Masimo Corp Unternehmen
Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The Company's measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry and advanced rainbow Pulse CO-Oximetry parameters. The Company's Non-healthcare business develops, manufactures, markets, sells home sound integration technologies and accessories, along with licensing complete high performance in-vehicle audio systems under consumer brands, such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology.
Unternehmensinformationen
BörsenkürzelMASI
Name des UnternehmensMasimo Corp
IPO-datumAug 08, 2007
CEOMs. Catherine M. (Katie) Szyman
Anzahl der mitarbeiter3600
WertpapierartOrdinary Share
GeschäftsjahresendeAug 08
Addresse52 Discovery
StadtIRVINE
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl92618
Telefon19492977000
Websitehttps://www.masimo.com/
BörsenkürzelMASI
IPO-datumAug 08, 2007
CEOMs. Catherine M. (Katie) Szyman
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Blair Tripodi
Mr. Blair Tripodi
Chief Operating Officer - Consumer Division
Chief Operating Officer - Consumer Division
8.61K
--
Dr. Darlene Solomon
Dr. Darlene Solomon
Independent Director
Independent Director
--
--
Mr. Eli Kammerman
Mr. Eli Kammerman
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Quentin Koffey
Mr. Quentin Koffey
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
--
--
Mr. Micah Wesley Young
Mr. Micah Wesley Young
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Catherine M. (Katie) Szyman
Ms. Catherine M. (Katie) Szyman
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Wendy E. Lane
Ms. Wendy E. Lane
Independent Director
Independent Director
--
--
Mr. Timothy J. (Tim) Scannell
Mr. Timothy J. (Tim) Scannell
Independent Director
Independent Director
--
--
Ms. Michelle M. Brennan
Ms. Michelle M. Brennan
Chairman of the Board
Chairman of the Board
--
--
Ms. Lisa Hellmann
Ms. Lisa Hellmann
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Blair Tripodi
Mr. Blair Tripodi
Chief Operating Officer - Consumer Division
Chief Operating Officer - Consumer Division
8.61K
--
Dr. Darlene Solomon
Dr. Darlene Solomon
Independent Director
Independent Director
--
--
Mr. Eli Kammerman
Mr. Eli Kammerman
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Quentin Koffey
Mr. Quentin Koffey
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
--
--
Mr. Micah Wesley Young
Mr. Micah Wesley Young
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Catherine M. (Katie) Szyman
Ms. Catherine M. (Katie) Szyman
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2024
FY2023
FY2022
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
United States
1.13B
53.84%
Europe, Middle East and Africa
595.60M
28.44%
Asia and Australia
303.50M
14.49%
North and South America (excluding the U.S.)
67.70M
3.23%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Sun, Aug 17
Aktualisiert: Sun, Aug 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Fidelity Management & Research Company LLC
12.78%
The Vanguard Group, Inc.
8.52%
Politan Capital Management, L.P.
8.45%
BlackRock Institutional Trust Company, N.A.
7.80%
BlackRock Investment Management (UK) Ltd.
5.66%
Andere
56.79%
Aktionäre
Aktionäre
Anteil
Fidelity Management & Research Company LLC
12.78%
The Vanguard Group, Inc.
8.52%
Politan Capital Management, L.P.
8.45%
BlackRock Institutional Trust Company, N.A.
7.80%
BlackRock Investment Management (UK) Ltd.
5.66%
Andere
56.79%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
53.31%
Investment Advisor/Hedge Fund
31.50%
Hedge Fund
16.60%
Individual Investor
5.97%
Research Firm
2.62%
Bank and Trust
1.67%
Pension Fund
1.15%
Venture Capital
0.21%
Sovereign Wealth Fund
0.17%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
937
59.97M
110.39%
-7.53M
2025Q1
981
59.62M
109.96%
-8.22M
2024Q4
950
56.99M
105.70%
-7.11M
2024Q3
945
55.24M
103.11%
-8.43M
2024Q2
962
54.27M
102.01%
-12.67M
2024Q1
1002
56.30M
106.05%
-9.64M
2023Q4
1090
55.26M
104.56%
-6.33M
2023Q3
1093
52.14M
98.67%
-6.57M
2023Q2
1090
50.54M
95.73%
-6.92M
2023Q1
1117
49.67M
94.09%
-7.79M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Fidelity Management & Research Company LLC
6.93M
12.79%
+25.96K
+0.38%
Mar 31, 2025
The Vanguard Group, Inc.
4.57M
8.43%
-3.43K
-0.07%
Mar 31, 2025
Politan Capital Management, L.P.
4.72M
8.73%
+1.79K
+0.04%
Apr 29, 2025
BlackRock Institutional Trust Company, N.A.
4.13M
7.62%
-1.41M
-25.40%
Mar 31, 2025
BlackRock Investment Management (UK) Ltd.
2.73M
5.04%
+1.17M
+74.98%
Mar 31, 2025
Kiani (Joe E)
4.11M
7.57%
-75.75K
-1.81%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
1.67M
3.09%
+10.88K
+0.65%
Mar 31, 2025
MFS Investment Management
1.96M
3.62%
+231.45K
+13.36%
Mar 31, 2025
Capital Research Global Investors
2.06M
3.79%
-398.88K
-16.25%
Mar 31, 2025
BlackRock Financial Management, Inc.
1.74M
3.21%
-207.54K
-10.65%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Sep 6
Aktualisiert: Sat, Sep 6
Name
Anteil
First Trust Indxx Medical Devices ETF
1.74%
First Trust Nasdaq Lux Digi Health Solutions ETF
1.68%
Hypatia Women CEO ETF
0.51%
Invesco NASDAQ Future Gen 200 ETF
0.38%
ProShares UltraPro MidCap400
0.23%
Strive Mid-Cap ETF
0.22%
SoFi Next 500 ETF
0.13%
PIMCO RAFI Dynamic Multi-Factor US Equity ETF
0.04%
Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF
0.03%
SPDR Russell 1000 Momentum Focus ETF
0.02%
Mehr Anzeigen
First Trust Indxx Medical Devices ETF
Anteil1.74%
First Trust Nasdaq Lux Digi Health Solutions ETF
Anteil1.68%
Hypatia Women CEO ETF
Anteil0.51%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.38%
ProShares UltraPro MidCap400
Anteil0.23%
Strive Mid-Cap ETF
Anteil0.22%
SoFi Next 500 ETF
Anteil0.13%
PIMCO RAFI Dynamic Multi-Factor US Equity ETF
Anteil0.04%
Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF
Anteil0.03%
SPDR Russell 1000 Momentum Focus ETF
Anteil0.02%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
